Fenilbutazona Mirc 20% 250ml.

Fenilbutazona Mirc 20% 250ml.

Laboratorio: Mirc Pharma
$23.00
USD / unidad
Out of stock

El presupuesto final se adapta según el volumen solicitado y el destino de entrega.

  • Distribución oficial habilitada por SENASA Establecimiento oficial y normativas sanitarias vigentes
  • Cadena de frío garantizada Monitoreo térmico para biológicos y sueros
  • Dirección técnica y asesoramiento veterinario Atención profesional especializada en medicina equina
  • Envíos nacionales e internacionales especializados Acondicionamiento térmico y logística segura
Fenilbutazona Mirc 20% 250ml.

Fenilbutazona Mirc 20% 250ml.

$23.00 USD Out of stock
Phenylbutazone-based injectable solution. A nonsteroidal anti-inflammatory drug with analgesic, antipyretic, and anti-inflammatory effects. Indicated for acute and chronic inflammatory conditions. Arthritis, myositis, tendinitis, synovitis, hyperthermia. FORMULA: Each 100 ml contains 20 g of phenylbutazone. Excipients q.s. DOSAGE: Adults: On the first day, administer 5 to 10 ml, which is equivalent to 1 to 2 ml per 100 kg of body weight or 2.2 to 4.4 mg/kg. Foals: On the first day, administer 1 to 2 ml for a foal weighing approximately 200 kg, equivalent to 1.1–2.2 mg/kg. Starting on the second day, reduce the dose by half until treatment is complete. CONTRAINDICATIONS: Use with caution when administered concomitantly with warfarin, aminoglycosides, penicillins, sulfonamides, furosemide, barbiturates, promazine, glucocorticoids, and other NSAIDs. Do not use in pregnant or lactating mares. Do not use in animals with known hypersensitivity to phenylbutazone. Do not administer to horses intended for human consumption. Do not administer to patients with heart, kidney, or liver failure; Gastroduodenal ulcer syndrome (GDUS); Or to animals that are dehydrated, hypovolemic, hypotensive, or have hematological or bone marrow abnormalities. At the indicated dose and duration of treatment, side effects are unlikely to occur. In cases of hypersensitivity, gastrointestinal symptoms may occur, such as oral and gastrointestinal ulcers, diarrhea, anorexia, decreased plasma protein concentration, neutropenia with a toxic left shift, and renal effects (azotemia, renal papillary necrosis). Do not mix with other medications in the same syringe. Administer only by the indicated route. INTENDED FOR: Equines not intended for human consumption. Do not administer to pregnant or lactating mares. DURATION OF TREATMENT: The duration of treatment may be up to 7 days, adhering to the dose reduction and dosing intervals. In acute cases, it may be administered every 12 hours on the first day and then every 24 hours. In subacute or chronic cases, administer every 24 hours. The duration of treatment is at the discretion of the treating veterinarian based on the clinical presentation. PACKAGING: Bottles of 100 ml and 250 ml
Laboratory Mirc Pharma
Sale condition Prescription required